HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-NOV-18 6N3L
TITLE IDENTIFICATION OF NOVEL, POTENT AND SELECTIVE GCN2 INHIBITORS AS
TITLE 2 FIRST-IN-CLASS ANTI-TUMOR AGENTS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: EIF-2-ALPHA KINASE GCN2,EIF-2-ALPHA KINASE GCN2;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 4,
COMPND 5 GCN2-LIKE PROTEIN,EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA
COMPND 6 KINASE 4,GCN2-LIKE PROTEIN;
COMPND 7 EC: 2.7.11.1;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: EIF2AK4, GCN2, KIAA1338;
SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469;
SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9
KEYWDS GCN2, KINASE, INHIBITOR, ANTI-TUMOR, TRANSFERASE-TRANSFERASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR I.D.HOFFMAN,J.FUJIMOTO,O.KURASAWA,T.TAKAGI,M.G.KLEIN,G.KEFALA,
AUTHOR 2 S.C.DING,D.R.CARY,R.MIZOJIRI
REVDAT 3 13-MAR-24 6N3L 1 REMARK
REVDAT 2 30-OCT-19 6N3L 1 JRNL
REVDAT 1 09-OCT-19 6N3L 0
JRNL AUTH J.FUJIMOTO,O.KURASAWA,T.TAKAGI,X.LIU,H.BANNO,T.KOJIMA,
JRNL AUTH 2 Y.ASANO,A.NAKAMURA,T.NAMBU,A.HATA,T.ISHII,T.SAMESHIMA,
JRNL AUTH 3 Y.DEBORI,M.MIYAMOTO,M.G.KLEIN,R.TJHEN,B.C.SANG,I.LEVIN,
JRNL AUTH 4 S.W.LANE,G.P.SNELL,K.LI,G.KEFALA,I.D.HOFFMAN,S.C.DING,
JRNL AUTH 5 D.R.CARY,R.MIZOJIRI
JRNL TITL IDENTIFICATION OF NOVEL, POTENT, AND ORALLY AVAILABLE GCN2
JRNL TITL 2 INHIBITORS WITH TYPE I HALF BINDING MODE.
JRNL REF ACS MED.CHEM.LETT. V. 10 1498 2019
JRNL REFN ISSN 1948-5875
JRNL PMID 31620240
JRNL DOI 10.1021/ACSMEDCHEMLETT.9B00400
REMARK 2
REMARK 2 RESOLUTION. 2.61 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6
REMARK 3 NUMBER OF REFLECTIONS : 17799
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.226
REMARK 3 R VALUE (WORKING SET) : 0.223
REMARK 3 FREE R VALUE : 0.290
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 960
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3802
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 68
REMARK 3 SOLVENT ATOMS : 48
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.55
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.76000
REMARK 3 B22 (A**2) : 0.49000
REMARK 3 B33 (A**2) : -2.26000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.817
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.364
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.340
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 37.065
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA
REMARK 3 BOND LENGTH (A) : NULL ; NULL
REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL
REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL
REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL
REMARK 3
REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL
REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL
REMARK 3
REMARK 3 NON-BONDED CONTACT RESTRAINTS.
REMARK 3 SINGLE TORSION (A) : NULL ; NULL
REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL
REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL
REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL
REMARK 3
REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS.
REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL
REMARK 3 PLANAR (DEGREES) : NULL ; NULL
REMARK 3 STAGGERED (DEGREES) : NULL ; NULL
REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS U VALUES : WITH TLS ADDED
REMARK 4
REMARK 4 6N3L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-18.
REMARK 100 THE DEPOSITION ID IS D_1000238122.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 24-SEP-14
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 5.0.3
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97648
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36200
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5
REMARK 200 DATA REDUNDANCY : 3.700
REMARK 200 R MERGE (I) : 0.11700
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64
REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5
REMARK 200 DATA REDUNDANCY IN SHELL : 3.20
REMARK 200 R MERGE FOR SHELL (I) : 0.86000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 39.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS 8.5, 24% PEG3350, 450 MM
REMARK 280 NAFORMATE, 1% HEXANEDIOL, PH 8.5, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.33700
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 60.33700
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 41.94300
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 61.11650
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 41.94300
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 61.11650
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 60.33700
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 41.94300
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 61.11650
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 60.33700
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 41.94300
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 61.11650
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 561
REMARK 465 HIS A 562
REMARK 465 HIS A 563
REMARK 465 HIS A 564
REMARK 465 HIS A 565
REMARK 465 HIS A 566
REMARK 465 HIS A 567
REMARK 465 GLU A 568
REMARK 465 ASN A 569
REMARK 465 LEU A 570
REMARK 465 TYR A 571
REMARK 465 PHE A 572
REMARK 465 GLN A 573
REMARK 465 GLY A 574
REMARK 465 GLY A 575
REMARK 465 SER A 576
REMARK 465 SER A 577
REMARK 465 GLU A 578
REMARK 465 THR A 579
REMARK 465 GLN A 580
REMARK 465 ARG A 581
REMARK 465 GLN A 582
REMARK 465 PHE A 583
REMARK 465 GLY A 782
REMARK 465 CYS A 783
REMARK 465 HIS A 784
REMARK 465 GLU A 785
REMARK 465 SER A 786
REMARK 465 GLU A 787
REMARK 465 PRO A 788
REMARK 465 SER A 789
REMARK 465 VAL A 790
REMARK 465 THR A 791
REMARK 465 THR A 792
REMARK 465 GLU A 793
REMARK 465 ALA A 794
REMARK 465 GLY A 868
REMARK 465 LEU A 869
REMARK 465 ALA A 870
REMARK 465 THR A 871
REMARK 465 ASP A 872
REMARK 465 HIS A 873
REMARK 465 LEU A 874
REMARK 465 ALA A 875
REMARK 465 PHE A 876
REMARK 465 SER A 877
REMARK 465 ALA A 878
REMARK 465 ASP A 879
REMARK 465 SER A 880
REMARK 465 LYS A 881
REMARK 465 GLN A 882
REMARK 465 ASP A 883
REMARK 465 ASP A 884
REMARK 465 GLN A 885
REMARK 465 THR A 886
REMARK 465 GLY A 887
REMARK 465 ASP A 888
REMARK 465 LEU A 889
REMARK 465 ILE A 890
REMARK 465 LYS A 891
REMARK 465 SER A 892
REMARK 465 ASP A 893
REMARK 465 PRO A 894
REMARK 465 SER A 895
REMARK 465 GLY A 896
REMARK 465 HIS A 897
REMARK 465 LEU A 898
REMARK 465 ALA A 899
REMARK 465 GLY A 900
REMARK 465 MET A 901
REMARK 465 VAL A 902
REMARK 465 GLY A 903
REMARK 465 VAL A 912
REMARK 465 GLN A 913
REMARK 465 GLY A 914
REMARK 465 SER A 915
REMARK 465 THR A 916
REMARK 465 LYS A 917
REMARK 465 SER A 918
REMARK 465 ALA A 919
REMARK 465 THR A 958
REMARK 465 SER A 959
REMARK 465 PRO A 960
REMARK 465 LYS A 961
REMARK 465 ASP A 967
REMARK 465 ASP A 968
REMARK 465 GLY A 969
REMARK 465 GLU A 970
REMARK 465 PRO A 1003
REMARK 465 PRO A 1004
REMARK 465 GLN A 1005
REMARK 465 MET A 1006
REMARK 465 GLU A 1007
REMARK 465 GLU A 1008
REMARK 465 SER A 1009
REMARK 465 GLU A 1010
REMARK 465 LEU A 1011
REMARK 465 HIS A 1012
REMARK 465 GLU A 1013
REMARK 465 MET B 561
REMARK 465 HIS B 562
REMARK 465 HIS B 563
REMARK 465 HIS B 564
REMARK 465 HIS B 565
REMARK 465 HIS B 566
REMARK 465 HIS B 567
REMARK 465 GLU B 568
REMARK 465 ASN B 569
REMARK 465 LEU B 570
REMARK 465 TYR B 571
REMARK 465 PHE B 572
REMARK 465 GLN B 573
REMARK 465 GLY B 574
REMARK 465 GLY B 575
REMARK 465 SER B 576
REMARK 465 SER B 577
REMARK 465 GLU B 578
REMARK 465 THR B 579
REMARK 465 GLN B 580
REMARK 465 ARG B 581
REMARK 465 GLN B 582
REMARK 465 PHE B 583
REMARK 465 ASN B 624
REMARK 465 PRO B 625
REMARK 465 ASN B 781
REMARK 465 GLY B 782
REMARK 465 CYS B 783
REMARK 465 HIS B 784
REMARK 465 GLU B 785
REMARK 465 SER B 786
REMARK 465 GLU B 787
REMARK 465 PRO B 788
REMARK 465 SER B 789
REMARK 465 VAL B 790
REMARK 465 THR B 791
REMARK 465 THR B 792
REMARK 465 GLU B 793
REMARK 465 ALA B 794
REMARK 465 VAL B 795
REMARK 465 GLY B 868
REMARK 465 LEU B 869
REMARK 465 ALA B 870
REMARK 465 THR B 871
REMARK 465 ASP B 872
REMARK 465 HIS B 873
REMARK 465 LEU B 874
REMARK 465 ALA B 875
REMARK 465 PHE B 876
REMARK 465 SER B 877
REMARK 465 ALA B 878
REMARK 465 ASP B 879
REMARK 465 SER B 880
REMARK 465 LYS B 881
REMARK 465 GLN B 882
REMARK 465 ASP B 883
REMARK 465 ASP B 884
REMARK 465 GLN B 885
REMARK 465 THR B 886
REMARK 465 GLY B 887
REMARK 465 ASP B 888
REMARK 465 LEU B 889
REMARK 465 ILE B 890
REMARK 465 LYS B 891
REMARK 465 SER B 892
REMARK 465 ASP B 893
REMARK 465 PRO B 894
REMARK 465 SER B 895
REMARK 465 GLY B 896
REMARK 465 HIS B 897
REMARK 465 LEU B 898
REMARK 465 ALA B 899
REMARK 465 GLY B 900
REMARK 465 MET B 901
REMARK 465 VAL B 902
REMARK 465 GLY B 903
REMARK 465 VAL B 912
REMARK 465 GLN B 913
REMARK 465 GLY B 914
REMARK 465 SER B 915
REMARK 465 THR B 916
REMARK 465 LYS B 917
REMARK 465 SER B 918
REMARK 465 ALA B 919
REMARK 465 THR B 958
REMARK 465 SER B 959
REMARK 465 PRO B 960
REMARK 465 LYS B 961
REMARK 465 ASP B 967
REMARK 465 ASP B 968
REMARK 465 GLY B 969
REMARK 465 GLU B 970
REMARK 465 PRO B 1003
REMARK 465 PRO B 1004
REMARK 465 GLN B 1005
REMARK 465 MET B 1006
REMARK 465 GLU B 1007
REMARK 465 GLU B 1008
REMARK 465 SER B 1009
REMARK 465 GLU B 1010
REMARK 465 LEU B 1011
REMARK 465 HIS B 1012
REMARK 465 GLU B 1013
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 593 -58.26 -123.42
REMARK 500 PRO A 625 152.29 -38.10
REMARK 500 ALA A 626 29.28 47.13
REMARK 500 ALA A 807 -156.84 -77.05
REMARK 500 ARG A 847 -15.53 81.80
REMARK 500 ASN A 848 29.49 -143.46
REMARK 500 ASP A 956 -163.77 -175.12
REMARK 500 ALA B 807 -153.01 -78.42
REMARK 500 ARG B 847 -20.28 83.50
REMARK 500 PRO B 910 -100.59 -39.37
REMARK 500 ASP B 956 -155.21 -178.79
REMARK 500 GLU B 999 44.39 -103.85
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 TYR A 920 ASN A 921 -147.40
REMARK 500 ASP A 956 PRO A 957 148.67
REMARK 500 TYR B 920 ASN B 921 -126.68
REMARK 500 ASP B 956 PRO B 957 144.62
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue KAV A 2501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue KAV B 2501
DBREF 6N3L A 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657
DBREF 6N3L A 782 1013 UNP Q9P2K8 E2AK4_HUMAN 782 1013
DBREF 6N3L B 577 657 UNP Q9P2K8 E2AK4_HUMAN 577 657
DBREF 6N3L B 782 1013 UNP Q9P2K8 E2AK4_HUMAN 782 1013
SEQADV 6N3L MET A 561 UNP Q9P2K8 INITIATING METHIONINE
SEQADV 6N3L HIS A 562 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS A 563 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS A 564 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS A 565 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS A 566 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS A 567 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLU A 568 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L ASN A 569 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L LEU A 570 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L TYR A 571 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L PHE A 572 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLN A 573 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLY A 574 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLY A 575 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L SER A 576 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L ASN A 658 UNP Q9P2K8 LINKER
SEQADV 6N3L ALA A 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION
SEQADV 6N3L ASN A 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION
SEQADV 6N3L ALA A 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION
SEQADV 6N3L ALA A 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION
SEQADV 6N3L MET B 561 UNP Q9P2K8 INITIATING METHIONINE
SEQADV 6N3L HIS B 562 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS B 563 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS B 564 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS B 565 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS B 566 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L HIS B 567 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLU B 568 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L ASN B 569 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L LEU B 570 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L TYR B 571 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L PHE B 572 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLN B 573 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLY B 574 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L GLY B 575 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L SER B 576 UNP Q9P2K8 EXPRESSION TAG
SEQADV 6N3L ASN B 781 UNP Q9P2K8 LINKER
SEQADV 6N3L ALA B 807 UNP Q9P2K8 LYS 807 ENGINEERED MUTATION
SEQADV 6N3L ASN B 848 UNP Q9P2K8 ASP 848 ENGINEERED MUTATION
SEQADV 6N3L ALA B 899 UNP Q9P2K8 THR 899 ENGINEERED MUTATION
SEQADV 6N3L ALA B 904 UNP Q9P2K8 THR 904 ENGINEERED MUTATION
SEQRES 1 A 330 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN
SEQRES 2 A 330 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR
SEQRES 3 A 330 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY
SEQRES 4 A 330 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP
SEQRES 5 A 330 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO
SEQRES 6 A 330 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR
SEQRES 7 A 330 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR
SEQRES 8 A 330 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU
SEQRES 9 A 330 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE
SEQRES 10 A 330 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR
SEQRES 11 A 330 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP
SEQRES 12 A 330 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE
SEQRES 13 A 330 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL
SEQRES 14 A 330 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY
SEQRES 15 A 330 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA
SEQRES 16 A 330 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS
SEQRES 17 A 330 SER ASP PRO SER GLY HIS LEU ALA GLY MET VAL GLY ALA
SEQRES 18 A 330 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS
SEQRES 19 A 330 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY
SEQRES 20 A 330 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR
SEQRES 21 A 330 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP
SEQRES 22 A 330 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY
SEQRES 23 A 330 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU
SEQRES 24 A 330 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU
SEQRES 25 A 330 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU
SEQRES 26 A 330 SER GLU LEU HIS GLU
SEQRES 1 B 330 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN
SEQRES 2 B 330 GLY GLY SER SER GLU THR GLN ARG GLN PHE SER ARG TYR
SEQRES 3 B 330 PHE ILE GLU PHE GLU GLU LEU GLN LEU LEU GLY LYS GLY
SEQRES 4 B 330 ALA PHE GLY ALA VAL ILE LYS VAL GLN ASN LYS LEU ASP
SEQRES 5 B 330 GLY CYS CYS TYR ALA VAL LYS ARG ILE PRO ILE ASN PRO
SEQRES 6 B 330 ALA SER ARG GLN PHE ARG ARG ILE LYS GLY GLU VAL THR
SEQRES 7 B 330 LEU LEU SER ARG LEU HIS HIS GLU ASN ILE VAL ARG TYR
SEQRES 8 B 330 TYR ASN ALA TRP ILE GLU ASN GLY CYS HIS GLU SER GLU
SEQRES 9 B 330 PRO SER VAL THR THR GLU ALA VAL HIS TYR LEU TYR ILE
SEQRES 10 B 330 GLN MET GLU TYR CYS GLU ALA SER THR LEU ARG ASP THR
SEQRES 11 B 330 ILE ASP GLN GLY LEU TYR ARG ASP THR VAL ARG LEU TRP
SEQRES 12 B 330 ARG LEU PHE ARG GLU ILE LEU ASP GLY LEU ALA TYR ILE
SEQRES 13 B 330 HIS GLU LYS GLY MET ILE HIS ARG ASN LEU LYS PRO VAL
SEQRES 14 B 330 ASN ILE PHE LEU ASP SER ASP ASP HIS VAL LYS ILE GLY
SEQRES 15 B 330 ASP PHE GLY LEU ALA THR ASP HIS LEU ALA PHE SER ALA
SEQRES 16 B 330 ASP SER LYS GLN ASP ASP GLN THR GLY ASP LEU ILE LYS
SEQRES 17 B 330 SER ASP PRO SER GLY HIS LEU ALA GLY MET VAL GLY ALA
SEQRES 18 B 330 ALA LEU TYR VAL SER PRO GLU VAL GLN GLY SER THR LYS
SEQRES 19 B 330 SER ALA TYR ASN GLN LYS VAL ASP LEU PHE SER LEU GLY
SEQRES 20 B 330 ILE ILE PHE PHE GLU MET SER TYR HIS PRO MET VAL THR
SEQRES 21 B 330 ALA SER GLU ARG ILE PHE VAL LEU ASN GLN LEU ARG ASP
SEQRES 22 B 330 PRO THR SER PRO LYS PHE PRO GLU ASP PHE ASP ASP GLY
SEQRES 23 B 330 GLU HIS ALA LYS GLN LYS SER VAL ILE SER TRP LEU LEU
SEQRES 24 B 330 ASN HIS ASP PRO ALA LYS ARG PRO THR ALA THR GLU LEU
SEQRES 25 B 330 LEU LYS SER GLU LEU LEU PRO PRO PRO GLN MET GLU GLU
SEQRES 26 B 330 SER GLU LEU HIS GLU
HET KAV A2501 34
HET KAV B2501 34
HETNAM KAV N-{6-[(1-METHYL-2-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}-
HETNAM 2 KAV 1H-BENZIMIDAZOL-5-YL)OXY]PYRIMIDIN-4-
HETNAM 3 KAV YL}CYCLOPROPANECARBOXAMIDE
FORMUL 3 KAV 2(C23 H19 F3 N6 O2)
FORMUL 5 HOH *48(H2 O)
HELIX 1 AA1 SER A 584 GLU A 589 1 6
HELIX 2 AA2 SER A 627 SER A 641 1 15
HELIX 3 AA3 THR A 809 GLN A 816 1 8
HELIX 4 AA4 GLY A 817 ARG A 820 5 4
HELIX 5 AA5 ASP A 821 LYS A 842 1 22
HELIX 6 AA6 LYS A 850 VAL A 852 5 3
HELIX 7 AA7 ALA A 904 VAL A 908 5 5
HELIX 8 AA8 LYS A 923 TYR A 938 1 16
HELIX 9 AA9 THR A 943 GLN A 953 1 11
HELIX 10 AB1 ALA A 972 LEU A 982 1 11
HELIX 11 AB2 ASP A 985 ARG A 989 5 5
HELIX 12 AB3 THR A 991 SER A 998 1 8
HELIX 13 AB4 ARG B 585 GLU B 589 1 5
HELIX 14 AB5 SER B 627 SER B 641 1 15
HELIX 15 AB6 THR B 809 GLN B 816 1 8
HELIX 16 AB7 GLY B 817 ARG B 820 5 4
HELIX 17 AB8 ASP B 821 LYS B 842 1 22
HELIX 18 AB9 LYS B 850 VAL B 852 5 3
HELIX 19 AC1 ALA B 904 VAL B 908 5 5
HELIX 20 AC2 LYS B 923 TYR B 938 1 16
HELIX 21 AC3 THR B 943 GLN B 953 1 11
HELIX 22 AC4 ALA B 972 LEU B 982 1 11
HELIX 23 AC5 ASP B 985 ARG B 989 5 5
HELIX 24 AC6 THR B 991 SER B 998 1 8
SHEET 1 AA1 5 PHE A 590 GLY A 599 0
SHEET 2 AA1 5 GLY A 602 ASN A 609 -1 O VAL A 604 N LEU A 596
SHEET 3 AA1 5 CYS A 615 PRO A 622 -1 O ARG A 620 N ALA A 603
SHEET 4 AA1 5 TYR A 797 GLU A 803 -1 O LEU A 798 N ILE A 621
SHEET 5 AA1 5 TYR A 651 GLU A 657 -1 N ASN A 653 O GLN A 801
SHEET 1 AA2 2 ILE A 854 LEU A 856 0
SHEET 2 AA2 2 VAL A 862 ILE A 864 -1 O LYS A 863 N PHE A 855
SHEET 1 AA3 5 PHE B 590 LYS B 598 0
SHEET 2 AA3 5 ALA B 603 ASN B 609 -1 O LYS B 606 N LEU B 593
SHEET 3 AA3 5 CYS B 615 PRO B 622 -1 O ARG B 620 N ALA B 603
SHEET 4 AA3 5 TYR B 797 GLU B 803 -1 O LEU B 798 N ILE B 621
SHEET 5 AA3 5 TYR B 651 ILE B 656 -1 N ASN B 653 O GLN B 801
SHEET 1 AA4 2 ILE B 854 LEU B 856 0
SHEET 2 AA4 2 VAL B 862 ILE B 864 -1 O LYS B 863 N PHE B 855
SITE 1 AC1 19 LEU A 596 VAL A 604 ALA A 617 LYS A 619
SITE 2 AC1 19 GLU A 636 LEU A 640 LEU A 643 MET A 802
SITE 3 AC1 19 GLU A 803 TYR A 804 CYS A 805 ALA A 807
SITE 4 AC1 19 MET A 844 HIS A 846 PHE A 855 ILE A 864
SITE 5 AC1 19 GLY A 865 ASP A 866 PHE A 867
SITE 1 AC2 21 LEU B 596 VAL B 604 ALA B 617 LYS B 619
SITE 2 AC2 21 GLU B 636 LEU B 640 LEU B 643 ILE B 648
SITE 3 AC2 21 VAL B 649 MET B 802 GLU B 803 TYR B 804
SITE 4 AC2 21 CYS B 805 ILE B 839 MET B 844 HIS B 846
SITE 5 AC2 21 PHE B 855 ILE B 864 GLY B 865 ASP B 866
SITE 6 AC2 21 PHE B 867
CRYST1 83.886 122.233 120.674 90.00 90.00 90.00 C 2 2 21 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011921 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008181 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008287 0.00000